Company / Return on Assets (ROA)
OCULAR THERAPEUTIX, INC Return on Assets (ROA) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-32.9%
FY2025
5-year range
-104.3% / -32.0%
FY2021-FY2025
Trend
+22.1%
vs FY2024
Sector context
#142 of 213
Health Care
What the data says
At -32.9%, OCULAR THERAPEUTIX, INC's return on assets (roa) ranks #142 of 213 in the Health Care sector. Return on Assets (ROA) has fluctuated over the past 10 years, ranging from -114.3% in FY2017 to -32.0% in FY2023.
Based on SEC 10-K filings.
-32.9% in FY2025 with a 5-year CAGR of +0.1%.
Declined from -32.0% to -32.9% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +71.3pp
- 5-Year Change
- +0.1pp
- 10-Year Change
- -
Sector benchmark
#142 of 213 in Health CareTop 67% of 213This company -32.9% Sector average -24.2%
▼
-36.2% below sector average
Key checks
Key Insights
- In FY2025, return on assets (roa) increased 22.1% year-over-year.
- Currently 8.7pp below the Health Care sector average.
- Peak return on assets (roa) was recorded in FY2023.
- Lowest return on assets (roa) in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 0.25 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -32.9% | +22.1% |
| FY2024 | -42.3% | -31.9% |
| FY2023 | -32.0% | +69.3% |
| FY2022 | -104.3% | -147.3% |
| FY2021 | -42.2% | -27.8% |
| FY2020 | -33.0% | +59.0% |
| FY2019 | -80.5% | +2.0% |
| FY2018 | -82.1% | +28.2% |
| FY2017 | -114.3% | -91.7% |
| FY2016 | -59.7% | -394.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026